ProShare Advisors LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,368
-59.3%
21,550
+5.4%
0.00%
Q2 2023$67,284
-10.9%
20,451
+11.3%
0.00%
Q1 2023$75,550
-36.1%
18,382
-8.8%
0.00%
Q4 2022$118,143
-3.2%
20,161
+11.3%
0.00%
Q3 2022$122,000
+52.5%
18,110
+4.1%
0.00%
Q2 2022$80,000
-9.1%
17,399
-21.1%
0.00%
Q1 2022$88,000
-45.3%
22,048
-14.4%
0.00%
Q4 2021$161,000
-30.3%
25,767
+5.2%
0.00%
-100.0%
Q3 2021$231,000
-43.9%
24,499
-19.3%
0.00%0.0%
Q2 2021$412,000
+7.0%
30,366
+27.7%
0.00%0.0%
Q1 2021$385,000
-35.3%
23,779
+6.3%
0.00%
-50.0%
Q4 2020$595,000
+440.9%
22,364
+103.6%
0.00%
+100.0%
Q3 2018$110,000
-45.3%
10,982
-2.5%
0.00%0.0%
Q2 2018$201,000
+6.9%
11,264
-5.7%
0.00%0.0%
Q1 2018$188,000
-12.1%
11,950
-8.1%
0.00%0.0%
Q4 2017$214,00013,0080.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders